A detailed history of Brainard Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Brainard Capital Management LLC holds 3,195 shares of BMY stock, worth $172,977. This represents 0.17% of its overall portfolio holdings.

Number of Shares
3,195
Previous 3,170 0.79%
Holding current value
$172,977
Previous $228 Million 2.91%
% of portfolio
0.17%
Previous 0.19%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$65.71 - $74.53 $1,642 - $1,863
25 Added 0.79%
3,195 $221 Million
Q4 2022

Feb 08, 2023

BUY
$68.48 - $81.09 $217,081 - $257,055
3,170 New
3,170 $228 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Brainard Capital Management LLC Portfolio

Follow Brainard Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brainard Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brainard Capital Management LLC with notifications on news.